Pfizer (PFE) Income Taxes Paid (2009 - 2026)

For the trailing twelve months through Sep 27, 2026, Income Taxes Paid at Pfizer was $4.98 billion, up 21.4% year-over-year; for FY2025, it was $4.69 billion, up 30.0% from FY2024.

• Annual Income Taxes Paid shows a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
• In prior years, Pfizer's Income Taxes Paid was $3.61 billion in FY2024 (+14.6%), $3.15 billion in FY2023 (-60.0%), $7.87 billion in FY2022 (+5.9%) and $7.43 billion in FY2021 (+135.6%).
• Quarterly Income Taxes Paid has run from a low of $72 million in Q1 2026 to a high of $4.48 billion in Q4 2021 over five years.
• On a year-over-year basis, Income Taxes Paid increased in five of the last eight quarters, with growth averaging 32.3%.
• The strongest year-over-year quarter for Income Taxes Paid in the past five years was Q4 2021, with growth of 533.3%; the weakest was Q4 2023, with a decline of 91.9%.
• According to Business Quant data, Income Taxes Paid for the three prior quarters was $3.47 billion (Q2 2026), $72 million (Q1 2026) and $1.02 billion (Q4 2025).